C63H61FN4O8Si — CID 10396313
N-[1-[(2R,3R,4R,5R)-5-[[tert-butyl(diphenyl)silyl]oxymethyl]-3-[1-(2-fluorophenyl)-4-methoxypiperidin-4-yl]oxy-4-(9-phenylxanthen-9-yl)oxyoxolan-2-yl]-2-oxopyrimidin-4-yl]benzamide (PubChem CID 10396313) has the molecular formula C63H61FN4O8Si and a molecular weight of 1049.29 g/mol. Its IUPAC name is N-[1-[(2R,3R,4R,5R)-5-[[tert-butyl(diphenyl)silyl]oxymethyl]-3-[1-(2-fluorophenyl)-4-methoxypiperidin-4-yl]oxy-4-(9-phenylxanthen-9-yl)oxyoxolan-2-yl]-2-oxopyrimidin-4-yl]benzamide.
| Compound Name | N-[1-[(2R,3R,4R,5R)-5-[[tert-butyl(diphenyl)silyl]oxymethyl]-3-[1-(2-fluorophenyl)-4-methoxypiperidin-4-yl]oxy-4-(9-phenylxanthen-9-yl)oxyoxolan-2-yl]-2-oxopyrimidin-4-yl]benzamide |
|---|---|
| PubChem CID | 10396313 |
| Molecular Formula | C63H61FN4O8Si |
| Molecular Weight | 1049.29 g/mol |
| Exact Mass | 1048.42 |
| IUPAC Name | N-[1-[(2R,3R,4R,5R)-5-[[tert-butyl(diphenyl)silyl]oxymethyl]-3-[1-(2-fluorophenyl)-4-methoxypiperidin-4-yl]oxy-4-(9-phenylxanthen-9-yl)oxyoxolan-2-yl]-2-oxopyrimidin-4-yl]benzamide |
| SMILES | COC1(O[C@@H]2[C@H](OC3(c4ccccc4)c4ccccc4Oc4ccccc43)[C@@H](CO[Si](c3ccccc3)(c3ccccc3)C(C)(C)C)O[C@H]2n2ccc(NC(=O)c3ccccc3)nc2=O)CCN(c2ccccc2F)CC1 |
| InChI | InChI=1S/C63H61FN4O8Si/c1-61(2,3)77(46-27-13-7-14-28-46,47-29-15-8-16-30-47)72-43-54-56(76-63(45-25-11-6-12-26-45)48-31-17-21-35-52(48)73-53-36-22-18-32-49(53)63)57(75-62(71-4)38-41-67(42-39-62)51-34-20-19-33-50(51)64)59(74-54)68-40-37-55(66-60(68)70)65-58(69)44-23-9-5-10-24-44/h5-37,40,54,56-57,59H,38-39,41-43H2,1-4H3,(H,65,66,69,70)/t54-,56-,57-,59-/m1/s1 |
| InChIKey | QGMKKMMGTQGIET-VECFMNNQSA-N |
| XLogP | 10.62 |
| TPSA | 122.61 Ų |
| H-Bond Donors | 1 |
| H-Bond Acceptors | 11 |
| Rotatable Bonds | 15 |
| Heavy Atoms | 77 |
| Complexity | — |
3 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 1049.29 |
| LogP ≤ 5 | 10.62 |
| H-Bond Donors ≤ 5 | 1 |
| H-Bond Acceptors ≤ 10 | 11 |
| Structural Alerts | {'alert_name': 'heavy_metal', 'substructure': 'N/A'}, {'alert_name': 'het-C-het_not_in_ring', 'substructure': 'N/A'} |
|---|